Vol 2004, No 46 (2004)

Table of Contents

Research & Development

Chiron and Xoma to Develop Anticancer Antibodies Abstract pdf
Business Review Editor

Licensing

Neurocrine Acquires Wyeth’s Financial Interest in Indiplon Abstract pdf
Business Review Editor
Serono and InDex in Ulcerative Colitis Deal Abstract pdf
Business Review Editor

Mergers & Acquisitions

Yamanouchi and Fujisawa Strive for Global Mega-Player Status with Merger Agreement Abstract pdf
Business Review Editor
Fisher Scientific to Buy Oxoid and Dharmacon for US$410 M Abstract pdf
Business Review Editor

Company Profile

Eisai Co. Ltd Abstract pdf
Business Review Editor

Distribution & Marketing

Mayne to Market Paxene® in the EU Abstract pdf
Business Review Editor


Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.